Kevin Matthew Pantalone DO ECNU, FACE
Diabetes, Lipid Metabolism
Director of Diabetes Initiatives
Join to View Full Profile
9500 Euclid AveDesk F-20Cleveland, OH 44195
Phone+1 216-445-9060
Fax+1 216-445-1656
Dr. Pantalone is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Cleveland Clinic FoundationFellowship, Endocrinology, Diabetes, and Metabolism, 2009 - 2011- Cleveland Clinic FoundationResidency, Internal Medicine, 2006 - 2009
Ohio University Heritage College of Osteopathic Medicine in AthensClass of 2006
Certifications & Licensure
OH State License 2006 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2D Start of enrollment: 2021 Jan 18
Publications & Presentations
PubMed
- Neurobeachin (NBEA) is a novel gene associated with GLP-1 receptor agonist associated weight loss.Arshiya Mariam-Smith, Joseph H Breeyear, Noah J Daniels, Kevin M Pantalone, Marcio L Griebeler
Diabetes, Obesity & Metabolism. 2025-10-01 - Prevalence of Diabetes-related Autoantibodies Among Individuals With Type 2 Diabetes From Primary Care and Endocrinology Community Practice Settings.Laura D Lomeli, Michelle D Lundholm, Huijun Xiao, Keren Zhou, Kevin M Pantalone
Endocrine Practice. 2025-09-01 - Changes in urine albumin-to-creatinine ratio and health care resource utilization and costs in patients with type 2 diabetes and chronic kidney disease.Kevin M Pantalone, Rakesh Singh, Aozhou Wu, Keith A Betts, Yan Chen
Journal of Managed Care & Specialty Pharmacy. 2025-08-22
Press Mentions
HMN 2025: How AI-Enabled Bundle of Sensors, Coaching Aids Type 2 Diabetes OutcomesAugust 27th, 2025- AI-Supported Coaching Shows Promise for Improving Glycemic ControlAugust 25th, 2025
- New Peer-Reviewed Study in New England Journal of Medicine Catalyst Finds Twin Health's AI Precision Treatment Significantly Improves Outcomes in Patients with Type 2 Diabetes and Reduces Reliance on Costly Medications, Including GLP-1sAugust 20th, 2025
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
